 Vancomycin
"Vancomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
| Descriptor ID |
D014640
|
| MeSH Number(s) |
D09.400.420.925 D12.644.233.925
|
| Concept/Terms |
AB-Vancomycin- AB-Vancomycin
- curasan Brand of Vancomycin Hydrochloride
Diatracin- Diatracin
- Dista Brand of Vancomycin Hydrochloride
VANCO-cell- VANCO-cell
- cell pharm Brand of Vancomycin Hydrochloride
Vanco-saar- Vanco-saar
- MIP Brand of Vancomycin Hydrochloride
Vancocin- Vancocin
- Vancomycin Lilly
- Vancocine
- Eli Lilly Brand of Vancomycin Hydrochloride
- Vancocin HCl
- Lilly Brand of Vancomycin Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Vancomycin".
Below are MeSH descriptors whose meaning is more specific than "Vancomycin".
This graph shows the total number of publications written about "Vancomycin" by people in this website by year, and whether "Vancomycin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2017 | 0 | 1 | 1 | | 2020 | 1 | 1 | 2 | | 2021 | 3 | 0 | 3 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vancomycin" by people in Profiles.
-
Ali AH, Buness CW, Fischer R, Holtmann GJ, Shah A, Lewindon P, Shah S, Ragnekar AS, Taylor AE, Goel A, Cox KL, Alrabadi L, Wadsworth S, Kulkarni SS, Lindor KD. Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023 06 01; 77(6):E174-E175.
-
Murphy ME, Tang Girdwood S, Goldman JL, Scheetz MH, Downes KJ. Precision dosing of vancomycin: in defence of AUC-guided therapy in children. J Antimicrob Chemother. 2021 09 15; 76(10):2494-2497.
-
Tillman EM, Goldman JL. Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children. Paediatr Drugs. 2021 Jul; 23(4):373-380.
-
Johnson KM, Fischer RT, Holtmann GJ, Shah A, Alrabadi L, Lewindon P. Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis. Hepatology. 2021 09; 74(3):1716-1717.
-
Barajas-Colon E, Warady BA. Streptococcus salivarius peritonitis in an infant receiving chronic peritoneal dialysis. Perit Dial Int. 2021 05; 41(3):341-343.
-
Burns AN, Goldman JL. A Moving Target-Vancomycin Therapeutic Monitoring. J Pediatric Infect Dis Soc. 2020 Sep 17; 9(4):474-478.
-
Olarte L. Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis. J Pediatric Infect Dis Soc. 2019 May 11; 8(2):187-188.
-
Butler D, Torres-Torres S, Pahud B, Myers A, Bass JA, St Peter SD, McCulloh R. Clostridium difficile Ileitis in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2017 06; 64(6):e156-e158.
-
Goldman JL, Harrison CJ, Myers AL, Jackson MA, Selvarangan R. No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric Staphylococcus aureus blood isolates. Pediatr Infect Dis J. 2014 Feb; 33(2):216-8.
-
Myers AL, Gaedigk A, Dai H, James LP, Jones BL, Neville KA. Defining risk factors for red man syndrome in children and adults. Pediatr Infect Dis J. 2012 May; 31(5):464-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|